I made a house call on an 90 year old patient yesterday. He lives with his wife in an idyllic house surrounded by vernal gardens and a wetland preserve.
1. Few people actually benefit from ‘breakthrough’ cancer immunotherapy
By and . March 8, 2017. Stat Topics. [We will try to see if the authors still believe this]
2. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs. JAMA Netw. 2019 May 3;2(5):e192535. Free Full Text at PMC.